Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
NCT01291082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2013-01-29
Summary
Prospective MR-imaging study : role of magnetic resonance (MR) and Diffusion weighted imaging (DWI) MR in staging and therapy assessment in breast cancer patients with bone metastases.
Conditions
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Steven Pans, MD · UZ Leuven Dept Radiology
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2013-04-30
- Completion
- 2013-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer
NCT02766530 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner
NCT05381077 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
NCT02376127 ·Status: COMPLETED
-
Quantitative MR Imaging in Locally Advanced Cervical Cancer
NCT03210428 ·Status: UNKNOWN
-
Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)
NCT05574920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
NCT06335069 ·Status: RECRUITING ·Phase: PHASE2
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NCT02180308 ·Status: COMPLETED
-
Wholebody MRI In Lung Cancer StagiNg
NCT02716051 ·Status: COMPLETED ·Phase: NA
-
FDG PET/CT in Breast Cancer Bone Mets
NCT01996046 ·Status: ACTIVE_NOT_RECRUITING
-
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
NCT01985971 ·Status: COMPLETED ·Phase: NA
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
NCT01892540 ·Status: COMPLETED ·Phase: NA
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques
NCT01339780 ·Status: COMPLETED ·Phase: NA
-
PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT01190566 ·Status: COMPLETED
-
Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.
NCT04343079 ·Status: RECRUITING ·Phase: NA
-
18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer
NCT05982496 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.
NCT05340569 ·Status: COMPLETED ·Phase: NA